GCM
FLNA

Gallacher Capital Management’s Filana Therapeutics FLNA Stock Holding History

Gallacher Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,800
Closed -$198 – 337
2024
Q4 		$198 Sell
19,800
-3,600
-15% -$63.2K ﹤0.01% 286
2024
Q3 		$336K Buy
23,400
+7,300
+45% +$168K 0.15% 179
2024
Q2 		$58.8K Buy
+16,100
New +$339K 0.03% 268
2023
Q3 		– Sell
-17,300
Closed -$13.5K – 271
2023
Q2 		$13.5K Buy
+17,300
New +$417K 0.01% 237
2023
Q1 		– Sell
-50,100
Closed -$26.2K – 270
2022
Q4 		$26.2K Buy
+50,100
New +$1.8M 0.02% 230

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
ML
Mayport LLC Newton, Massachusetts $645M AUM 19.45% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Gallacher Capital Management's FLNA Position: Q2 2026 in Review

Gallacher Capital Management sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 64,972 shares — an estimated $110K sold.

Gallacher Capital Management first reported a position in FLNA in Q4 2022 and held it in 14 quarters. The position peaked at $17.4M in Q4 2022. 31 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Gallacher Capital Management reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Gallacher Capital Management sold 64,972 Filana Therapeutics shares in Q2 2026, an estimated $110K.
  • Gallacher Capital Management first reported a position in Filana Therapeutics in Q4 2022 and held it in 14 quarters.
  • Gallacher Capital Management's Filana Therapeutics position peaked at $17.4M in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.